Best treatment for small HER-2–positive, node-negative breast cancers unknown
By Beth Backus
HemOnc today
About 25% of breast cancers diagnosed in the United States are HER-2–positive. Research has established that the HER-2 phenotype is associated with poor DFS and OS.